State Street Corporation 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 10:26 am Sale |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
STATE STREET CORP STT |
1,525,045 1.620% |
-2,154,340 (-58.55%) |
Filing |
| 2023-02-08 10:03 am Purchase |
2022-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
STATE STREET CORP STT |
3,679,385 6.040% |
3,679,385 (New Position) |
Filing |